A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3

NCT05160558 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

8

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor's Decision

Conditions

Spinocerebellar Ataxia Type 3

Interventions

DRUG: BIIB132
DRUG: BIIB132-Matching Placebo

Sponsor

Biogen